<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02665377</url>
  </required_header>
  <id_info>
    <org_study_id>SahlgrenskaUHMT01</org_study_id>
    <nct_id>NCT02665377</nct_id>
  </id_info>
  <brief_title>Prevention of Akute Kidney Injury, Hearttransplant, ANP</brief_title>
  <official_title>Prevention of Akute Kidney Injury With Human Atrial Natriuretic Peptide in Patients Undergoing Heart Transplant.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, blinded, placebo-controlled trial. Patients: Adult patients (&gt;18 years of age)
      undergoing de novo Htx, with a preoperative GFR &gt; 30ml/min, not receiving an ABO-incompatible
      organ with an ischemia time of &gt; 6 hours. A donor age &gt; 70 years is an exclusion criteria.

      Intervention: Infusion of h-ANP fore five days, starting at the induction of anesthesia.

      Outcome: Kidney function, evaluated with serum creatinine day 1-7 and kidney clearance, 4-5
      Days after Htx plus after 3 and 12 months.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>GFR 4-5 days after Htx</measure>
    <time_frame>4-5 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>GFR 1 year after Htx</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>ANP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Infusion of h-ANP at dose of 50ng/kg/min fore 5 days, starting at the induction of anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Infusion of NaCl at the same volyme as for ANP for 5 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ANP</intervention_name>
    <arm_group_label>ANP</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  De novo Htx.

          -  Preoperative GFR &gt; 30ml/min/1,73m2.

          -  &gt;18 years old.

          -  Written consent.

        Exclusion Criteria:

          -  Multi organ transplantation or previous heart transplant.

          -  ECMO

          -  Donor age &gt; 70 years.

          -  Dialysis.

          -  ABO-incompatible organ.

          -  Donor heart ischemia time &gt; 6 tim.

          -  Known kidney disease.

          -  Other planed study within 2 mounth.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sven-Erik Ricksten, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sahlgrenska universitetssjukhuset</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Tholén, MD</last_name>
    <phone>+463124228789</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sven-Erik Ricksten, Prof</last_name>
    <phone>+46313427433</phone>
    <email>sven-erik.ricksten@aniv.gu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sahlgrenska sjukhuset</name>
      <address>
        <city>Gothenburg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sven-Erik Ricksten, Prof</last_name>
      <phone>+46313427433</phone>
      <email>sven-erik.ricksten@aniv.gu.se</email>
    </contact>
    <contact_backup>
      <last_name>Maria Tholén, MD</last_name>
      <phone>031 342 87 89</phone>
      <email>maria.tholen@vgregion.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 22, 2016</study_first_submitted>
  <study_first_submitted_qc>January 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2016</study_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Maria Tholén</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

